Shannon Lensing, DPM
Foot & Ankle Surgery · Omaha, NENPI 1487981320
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Stryker at 34.5% of the total. Reporting peaked in 2022 at $3,846 and has fallen 55.1% since, to $1,729 in 2025.
Across 193 payments — averaging $59.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Organogenesis Inc.$2K
- Arthrex$1K
- Paragon 28, Inc.$1K
- Conetic Solutions, Inc.$619
- Musculoskeletal Transplant Foundation Inc.$529
- plus $1K from 14 others
What the payments were for
- Travel & lodging$4,30238%
- Food & beverage$5,92352%
- Education$1,20011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 51 | $3,936 |
| Organogenesis Inc. | 71 | $2,426 |
| Arthrex | 5 | $1,456 |
| Paragon 28, Inc. | 7 | $1,246 |
| Conetic Solutions, Inc. | 4 | $619 |
| Musculoskeletal Transplant Foundation Inc. | 5 | $529 |
| Smith+Nephew | 17 | $386 |
| Orthofix Medical, Inc. | 8 | $148 |
| Paratek Pharmaceuticals, Inc. | 6 | $115 |
| Penumbra, Inc. | 1 | $106 |
| Johnson & Johnson | 3 | $100 |
| Kerecis Limited | 2 | $91 |
| Amgen | 3 | $49 |
| Solventum Corporation | 2 | $47 |
| Convatec Inc. | 2 | $41 |
| Biocomposites Inc | 1 | $38 |
| Nevro Corp. | 2 | $36 |
| Hydrofera LLC | 1 | $27 |
| Medtronic | 1 | $15 |
| Integra Lifesciences Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$1,972
- Product Portfolio$1,113
- PURAPLY WOUND MATRIX$881
- Apligraf$881
- CYGNUS DUAL$881
- NOVACHOR$881
- Affinity$881
- ORTHOLOC 2 LAPIFUSE$620
- Viaflow$490
- VARIAX$315
- AUGMENT INJECTABLE$315
- PuraPly$239
- Indigo$212
- OMEGA$173
- CITREFIX$169
- ANCHORAGE$128
- Bone Anchors with Arthroscopic Delivery System$119
How this compares
$11,425 in reported general payments places this provider in the 65th percentile of 43 foot & ankle surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 11 | $11,698 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 21 | $589 |
| Ciclopirox | 18 | $557 |
| Gabapentin | 37 | $277 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $252 |
| Terbinafine Hcl | 18 | $170 |
| Mupirocin | 21 | $165 |
| Methylprednisolone | 14 | $115 |
| Meloxicam | 20 | $28 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Omaha
- Bradley CoppleOmaha$83K
- Robert GreenhagenOmaha$29K
- Patrick NelsonOmaha$28K
- Jonathan RouseOmaha$20K
- Scott NelsonOmaha$16K
- Jordan SikesOmaha$15K
- Jorge AmaroOmaha$10K
- Kevin GrosshansOmaha$8K
- Kent DinucciOmaha$4K
- Reanen MichaelOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.